[
    {
        "headline": "Trump's drug price order is part request, part threat: Analyst",
        "text": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination&nbsp;here."
    },
    {
        "headline": "Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025",
        "text": "RAHWAY, N.J., May 13, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research across more than 25 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting (May 30–June 3). Data highlight Merck’s commitment to rapidly advance research across multiple tumor types and continue to build on its portfolio of e"
    },
    {
        "headline": "Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy",
        "text": "We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected […]"
    },
    {
        "headline": "Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers",
        "text": "The \"Magnificent Seven,\" made up of Nvidia (NVDA), Alphabet (GOOG, GOOGL), Tesla (TSLA), Microsoft (MSFT), Amazon (AMZN), Meta (META), and Apple (AAPL), are rallying after the US and China agreed to lower tariff rates for a 90-day period. Airline stocks, like American Airlines (AAL), Delta (DAL), and United Airlines (UAL), are also gaining on the trade deal. Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more expert insights and analysis on the latest market action, check out more Morning Brief&nbsp;here."
    },
    {
        "headline": "MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification",
        "text": "Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates."
    },
    {
        "headline": "Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now?",
        "text": "We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional […]"
    },
    {
        "headline": "Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings",
        "text": "The subdued stock price reaction suggests that Merck & Co., Inc.'s ( NYSE:MRK ) strong earnings didn't offer any..."
    },
    {
        "headline": "Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto",
        "text": "RAHWAY, N.J., May 08, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), and Kansas Governor Laura Kelly jointly announced today the $895 million expansion of Merck Animal Health’s manufacturing facility in De Soto, Kansas."
    },
    {
        "headline": "Is Merck & Co., Inc. (MRK) the Best Dow Stock?",
        "text": "We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Dow stocks. The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US. It represents the strength […]"
    },
    {
        "headline": "Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health",
        "text": "Merck (NYSE:MRK) recently announced the launch of a next-generation digital ecosystem for Growth Hormone Deficiency, a move that underscores its commitment to innovative patient care. This development adds a counterbalance to broader market trends, where mixed investor sentiment is influenced by anticipation of Federal Reserve interest rate decisions and ongoing trade discussions. While Merck's shares declined by 3% over the last month, this shift aligns with the flat market performance,..."
    },
    {
        "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
        "text": "We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $84.71 as of April 29th. MRK’s trailing and forward P/E were 12.31 and 9.45 respectively according to Yahoo Finance. Merck’s […]"
    },
    {
        "headline": "Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential",
        "text": "We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Billionaire Mario Gabelli’s other large-cap stock picks with huge upside potential. Mario Gabelli needs no introduction, having risen to […]"
    },
    {
        "headline": "Merck to Participate in the Bank of America 2025 Global Healthcare Conference",
        "text": "RAHWAY, N.J., May 07, 2025--Merck to Participate in the Bank of America 2025 Global Healthcare Conference"
    },
    {
        "headline": "Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck",
        "text": "Merck stock is showing high implied volatility. Option traders can take advantage of that by selling a what is called a \"short strangle.\""
    },
    {
        "headline": "Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?",
        "text": "We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other most profitable cheap stocks to buy. US stocks rose on Friday, May 2, as the S&P 500, Dow Jones […]"
    },
    {
        "headline": "Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company”",
        "text": "We recently published Jim Cramer’s Surprised About US Travel As He Discusses These 18 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that Jim Cramer discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on the […]"
    },
    {
        "headline": "Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know",
        "text": "Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects."
    },
    {
        "headline": "Top Dividend Stocks To Consider In May 2025",
        "text": "The United States market has experienced a positive trend, climbing 2.7% in the last week and achieving a 9.6% increase over the past year, with earnings projections indicating an annual growth of 14% in the coming years. In this favorable environment, identifying dividend stocks that offer consistent payouts and potential for capital appreciation can be an effective strategy for investors seeking to balance income generation with growth opportunities."
    },
    {
        "headline": "Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?",
        "text": "We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against other best and worst dow stocks for the next 12 months. The Dow Jones Industrial Average (DJIA), or the […]"
    },
    {
        "headline": "Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential",
        "text": "We recently published a list of Billionaire Cliff Asness’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other billionaire Cliff Asness’ stock picks with huge upside potential. Cliff Asness, the founder, managing principal, and chief investment officer […]"
    },
    {
        "headline": "Trump's drug price order is part request, part threat: Analyst",
        "text": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination&nbsp;here."
    },
    {
        "headline": "Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025",
        "text": "RAHWAY, N.J., May 13, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research across more than 25 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting (May 30–June 3). Data highlight Merck’s commitment to rapidly advance research across multiple tumor types and continue to build on its portfolio of e"
    },
    {
        "headline": "Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy",
        "text": "We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief Investment Officer at Fidelity International, the effect of tariffs is expected […]"
    },
    {
        "headline": "Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers",
        "text": "The \"Magnificent Seven,\" made up of Nvidia (NVDA), Alphabet (GOOG, GOOGL), Tesla (TSLA), Microsoft (MSFT), Amazon (AMZN), Meta (META), and Apple (AAPL), are rallying after the US and China agreed to lower tariff rates for a 90-day period. Airline stocks, like American Airlines (AAL), Delta (DAL), and United Airlines (UAL), are also gaining on the trade deal. Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more expert insights and analysis on the latest market action, check out more Morning Brief&nbsp;here."
    },
    {
        "headline": "MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification",
        "text": "Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.6% year on year to $15.53 billion. The company expects the full year’s revenue to be around $64.85 billion, close to analysts’ estimates. Its non-GAAP profit of $2.22 per share was 4% above analysts’ consensus estimates."
    },
    {
        "headline": "Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now?",
        "text": "We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best income stocks. Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional […]"
    },
    {
        "headline": "Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings",
        "text": "The subdued stock price reaction suggests that Merck & Co., Inc.'s ( NYSE:MRK ) strong earnings didn't offer any..."
    },
    {
        "headline": "Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto",
        "text": "RAHWAY, N.J., May 08, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), and Kansas Governor Laura Kelly jointly announced today the $895 million expansion of Merck Animal Health’s manufacturing facility in De Soto, Kansas."
    },
    {
        "headline": "Is Merck & Co., Inc. (MRK) the Best Dow Stock?",
        "text": "We recently published a list of The Best and Worst Dow Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Dow stocks. The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US. It represents the strength […]"
    },
    {
        "headline": "Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health",
        "text": "Merck (NYSE:MRK) recently announced the launch of a next-generation digital ecosystem for Growth Hormone Deficiency, a move that underscores its commitment to innovative patient care. This development adds a counterbalance to broader market trends, where mixed investor sentiment is influenced by anticipation of Federal Reserve interest rate decisions and ongoing trade discussions. While Merck's shares declined by 3% over the last month, this shift aligns with the flat market performance,..."
    },
    {
        "headline": "Merck & Co., Inc. (MRK): A Bull Case Theory",
        "text": "We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Investing Intel. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $84.71 as of April 29th. MRK’s trailing and forward P/E were 12.31 and 9.45 respectively according to Yahoo Finance. Merck’s […]"
    },
    {
        "headline": "Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential",
        "text": "We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Billionaire Mario Gabelli’s other large-cap stock picks with huge upside potential. Mario Gabelli needs no introduction, having risen to […]"
    },
    {
        "headline": "Merck to Participate in the Bank of America 2025 Global Healthcare Conference",
        "text": "RAHWAY, N.J., May 07, 2025--Merck to Participate in the Bank of America 2025 Global Healthcare Conference"
    },
    {
        "headline": "Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck",
        "text": "Merck stock is showing high implied volatility. Option traders can take advantage of that by selling a what is called a \"short strangle.\""
    },
    {
        "headline": "Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?",
        "text": "We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other most profitable cheap stocks to buy. US stocks rose on Friday, May 2, as the S&P 500, Dow Jones […]"
    }
]